SARS CoV 2 News and Research

RSS

How feasible is at-home antibody testing for COVID-19?

Researchers at King’s College, London, have found that self-administered, at-home antibody testing could be a simple method for virus surveillance on university campuses.

29 Jan 2021

Researchers develop ‘next-generation vaccine platform’ against SARS-CoV-2

Researchers have designed a subunit vaccine based on the SARS-CoV-2 spike protein co-administered with CpG (Oligodeoxyribonucleotides) adjuvant.

29 Jan 2021

Simulation can be a viable way to refine new medical guidelines for COVID-19

Simulation can be a viable way to quickly evaluate and refine new medical guidelines and educate hospital staff in new procedures, a recent study from UT Southwestern's Department of Pediatrics shows.

28 Jan 2021

Self- or caregiver swabs are as effective as healthcare worker swabs for detecting pathogens

Self swabs and caregiver swabs are effective at detecting multiple pathogens and are just as accurate as those taken by healthcare workers, according to a team of Australian researchers.

28 Jan 2021

Viruses like SARS-CoV-2 may be more widespread than previously thought

Researchers in Cambodia, France, and the United States have conducted a study indicating that viruses related to SARS-CoV-2 – the agent that causes COVID-19 – are far more geographically widespread than previously thought.

28 Jan 2021

Variants emerging during COVID-19 pandemic resist antibody neutralization

Researchers in the U.S. have warned that recently emerged variants of SARS-CoV-2 have become worryingly resistant to monoclonal antibody therapies, plasma from convalescent patients and sera from vaccinated individuals.

28 Jan 2021

SARS-CoV-2 is resistant to extreme variations in temperature, finds study

A recent study from Belize and Taiwan shows that four essential proteins of SARS-CoV-2 are well adapted to habitable temperatures and exhibit extreme thermostability, which means temperature changes between the winter and summer months have a negligible effect on the viral spread.

28 Jan 2021

Can the US keep covid variants in check? Here’s what it takes

The covid-19 variants that have emerged in the United Kingdom, Brazil, South Africa and now Southern California are eliciting two notably distinct responses from U.S. public health officials.

28 Jan 2021

Neurological and psychiatric complications six months after COVID-19 recovery

Researchers in the United Kingdom have aimed to determine the prevalence of patients who experience neurological and psychiatric conditions six months after recovering from COVID-19.

28 Jan 2021

Moderna vaccine shows robust suppression of SARS-CoV-2 infection in animal model

Researchers have demonstrated that the prime or prime-boost vaccination of Moderna vaccine in hamsters induced robust neutralizing antibodies, ameliorated weight loss, and suppressed SARS-CoV-2 replication in the airways.

28 Jan 2021

COVID-19 patients in high-altitude ICUs had improved survival in case study

A team of researchers in Ecuador and the U.K. found that high altitudes may be linked to improved COVID-19 survival – particularly among patients with no comorbidities.

28 Jan 2021

Viral ExoN regulates the rate of recombination in SARS-CoV-2

Researchers at Vanderbilt University Medical Center (VUMC) and the University of Texas Medical Branch (UTMB) at Galveston have discovered what may be the Achilles' heel of the coronavirus, a finding that may help close the door on COVID-19 and possibly head off future pandemics.

28 Jan 2021

COVID-19 vaccines should be given to pregnant or breastfeeding people, argue experts

People who are pregnant, breastfeeding or trying to conceive should be offered the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine based on ethical grounds, argue authors of a commentary in CMAJ (Canadian Medical Association Journal).

28 Jan 2021

Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2

Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2, preventing expression of genes that encode proteins in cells such as resident macrophages in the nose and pulmonary alveoli, and epithelial cells lining the alveoli, all of which are entry points for the virus.

28 Jan 2021